B cell depletion in patients with MS resulted in a B cell–GM-CSF-dependent decrease of pro-inflammatory myeloid-cell responses, highlighting the potential pathogenic role of this B cell population in vivo and revealing a novel disease-implicated axis involving B cell:myeloid-cell interactions (72). Here, CSF2 is linked to myeloid sarcoma.